Page 97 - RusRPTDec18

The market for domestically produced equipment is estimated at RUB255bn ($4bn).
According to data from the Oncology Association of Russia, the state funding of oncology treatment is going to go up 57% y/y in 2019 to RUB 217bn. State spending on chemotherapy is to double y/y to RUB 153bn. Cancer is one of the main focus areas of the government’s health initiatives with a target of reducing the mortality rate 6% by 2024 to 185 cases for every 100,000 citizens. Private healthcare providers have, of late, been actively participating in services under the mandatory health insurance scheme, as its premiums allow them to earn decent returns and improve utilisation rates. This improved financing could make the oncology segment a new growth pillar for private providers and we see it becoming an important revenue generator for MDMG at the growing Lapino cluster. The company anticipates the second stage of the hospital being launched in 2020 and a spike in the roll out of new services. This would come in addition to its unmatched expertise in treating women and the company ramping up its cardiology department.
97 RUSSIA Country Report December 2018 www.intellinews.com